The first novel drug for Alzheimer’s disease since 2003 has just been approved – in China.
It’s not that others haven’t tried…
In the U.S. alone, billions of dollars have been burned through, year after year… yet there’s been ZERO success.
The funding isn’t the problem.
It’s the fundamental principles behind what Big Pharma is trying to do!
Because the researchers they’ve got in their pockets are OVERLOOKING one of the most ancient, natural sources of “brain food.”
A dark horse, however, has stepped up to the plate with something NEW that leverages those ancient principles…
And it looks like it might actually provide a cognitive benefit that LASTS.
Not so surprising (if you’ve been paying attention)
A little-known Chinese pharmaceutical company has just broken through the barriers of treating mild-to-moderate Alzheimer’s disease.
It’s fast-tracking the launch of an AD drug that’s been developed using, the company says, “a holistic view of treatment.”
And that “whole-body” perspective may be what’s been MISSING from all other Alzheimer’s drug development efforts over the last 17 years.
Their drug, called “oligomannate,” comes out of research focused on Traditional Chinese Medicine … and is based on a natural compound called “sodium oligo-mannurarate.”
The preliminary results of a Phase III clinical trial involving over 800 older folks has JUST been released…
And quite frankly, the results are ASTONISHING – especially considering how Big Pharma’s drugs for Alzheimer’s have so dramatically FAILED.
Many drugmakers have DITCHED new Alzheimer’s drugs they were trying to develop.
Oligomannate isn’t like those other drugs, though… because this unique compound is based on an extract from marine brown algae.
That’s right – seaweed!
We already know how populations that eat lots of seaweed tend to show a lower risk of developing Alzheimer’s.
And we’ve shared with you before right here in eAlert how certain types of seaweed can DRIVE excess sugar out of your brain.
It can even keep your brain youthful, despite your age.
Well, here’s MORE evidence in support of this slimy “sea vegetable”…
In the study, cognition was significantly IMPROVED by the fourth week… and the improvements LASTED throughout the 9-month treatment period.
In fact, the study’s lead researcher says that patients’ cognitive function CONTINUED to improve over the course of the study.
Based on animal studies conducted before the trials on humans, the theory is that oligomannate eases Alzheimer’s symptoms NOT by targeting the brain directly…
But by RECONDITIONING the gut microbiome.
For years, we’ve known about the “gut-brain axis”… and how the bugs in your belly can affect your immunity and your mood.
There’s another mechanism at play here…
Oligomannate may help balance “good” and “bad” inflammation.
What’s the difference?
Good inflammation is part of a healthy process that actually protects your brain…
While the bad stuff can damage brain cells and promote dysfunction and cognitive impairment.
And what usually regulates that inflammatory response… and REINS IN harmful neuroinflammation?
Your immune system – which brings us back to your microbiome.
When your gut flora is out of balance (a.k.a. “gut dysbiosis”), the resulting excess inflammation can cause systemic health problems.
Yes, that includes in your brain, too.
The Shanghai-based manufacturer of the drug, Green Valley, plans to file for FDA approval in the U.S. and for regulatory clearances in Europe and the rest of Asia, too – starting as soon as early next year.
In the meantime, you can try experimenting with adding more seaweed to your diet.
Also available at your local health food store or online are tried-and-true supplements of “superfood seaweeds,” like chlorella (green algae) and spirulina (blue-green algae).